BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19276385)

  • 1. Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.
    Rong Y; Belozerov VE; Tucker-Burden C; Chen G; Durden DL; Olson JJ; Van Meir EG; Mackman N; Brat DJ
    Cancer Res; 2009 Mar; 69(6):2540-9. PubMed ID: 19276385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic activation of wild-type epidermal growth factor receptor and loss of Cdkn2a cause mouse glioblastoma formation.
    Acquaviva J; Jun HJ; Lessard J; Ruiz R; Zhu H; Donovan M; Woolfenden S; Boskovitz A; Raval A; Bronson RT; Pfannl R; Whittaker CA; Housman DE; Charest A
    Cancer Res; 2011 Dec; 71(23):7198-206. PubMed ID: 21987724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of phosphatidylinositol 3-kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells.
    Klingler-Hoffmann M; Bukczynska P; Tiganis T
    Int J Cancer; 2003 Jun; 105(3):331-9. PubMed ID: 12704666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTX3 gene activation in EGF-induced head and neck cancer cell metastasis.
    Chang WC; Wu SL; Huang WC; Hsu JY; Chan SH; Wang JM; Tsai JP; Chen BK
    Oncotarget; 2015 Apr; 6(10):7741-57. PubMed ID: 25797258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will kinase inhibitors make it as glioblastoma drugs?
    Mellinghoff IK; Schultz N; Mischel PS; Cloughesy TF
    Curr Top Microbiol Immunol; 2012; 355():135-69. PubMed ID: 22015553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells.
    Li HF; Kim JS; Waldman T
    Radiat Oncol; 2009 Oct; 4():43. PubMed ID: 19828040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma.
    Li L; Puliyappadamba VT; Chakraborty S; Rehman A; Vemireddy V; Saha D; Souza RF; Hatanpaa KJ; Koduru P; Burma S; Boothman DA; Habib AA
    Oncogene; 2015 Jan; 34(1):129-134. PubMed ID: 24362532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Hyaluronic Acid Influences the Efficacy of EGFR Tyrosine Kinase Inhibitors in a Biomaterial Model of Glioblastoma.
    Pedron S; Hanselman JS; Schroeder MA; Sarkaria JN; Harley BAC
    Adv Healthc Mater; 2017 Nov; 6(21):. PubMed ID: 28766870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.
    Huang K; Fang C; Yi K; Liu X; Qi H; Tan Y; Zhou J; Li Y; Liu M; Zhang Y; Yang J; Zhang J; Li M; Kang C
    Theranostics; 2018; 8(6):1540-1557. PubMed ID: 29556340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intron 1-Mediated Regulation of
    Jameson NM; Ma J; Benitez J; Izurieta A; Han JY; Mendez R; Parisian A; Furnari F
    Mol Cancer Res; 2019 Nov; 17(11):2208-2220. PubMed ID: 31444232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma.
    Fang R; Chen X; Zhang S; Shi H; Ye Y; Shi H; Zou Z; Li P; Guo Q; Ma L; He C; Huang S
    Nat Commun; 2021 Jan; 12(1):177. PubMed ID: 33420027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3-Kinase dependent upregulation of the epidermal growth factor receptor upon Flotillin-1 depletion in breast cancer cells.
    Kurrle N; Ockenga W; Meister M; Völlner F; Kühne S; John BA; Banning A; Tikkanen R
    BMC Cancer; 2013 Dec; 13():575. PubMed ID: 24304721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPA
    Valdés-Rives SA; Arcos-Montoya D; de la Fuente-Granada M; Zamora-Sánchez CJ; Arias-Romero LE; Villamar-Cruz O; Camacho-Arroyo I; Pérez-Tapia SM; González-Arenas A
    Cells; 2021 Apr; 10(4):. PubMed ID: 33916643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of EGFR, ERK-1,2 and AKT-1,2 Activity on Human Glioma Cell Growth.
    Alahverdi A; Arefian E; Soleimani M; Ai J; Yousefi-Ahmadipour A; Babaei A; Islam MS; Ebrahimi-Barough S
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3469-3475. PubMed ID: 33369441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR-A Potential Therapeutic Target.
    Zalcman N; Gutreiman M; Shahar T; Weller M; Lavon I
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acridine yellow G blocks glioblastoma growth via dual inhibition of epidermal growth factor receptor and protein kinase C kinases.
    Qi Q; He K; Yoo MH; Chan CB; Liu X; Zhang Z; Olson JJ; Xiao G; Wang L; Mao H; Fu H; Tao H; Ramalingam SS; Sun SY; Mischel PS; Ye K
    J Biol Chem; 2012 Feb; 287(9):6113-27. PubMed ID: 22215664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Invasion Factor ODZ1 Is Upregulated through an Epidermal Growth Factor Receptor-Induced Pathway in Primary Glioblastoma Cells.
    Velasquez C; Gutierrez O; Carcelen M; Fernandez-Luna JL
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma.
    Walsh AM; Kapoor GS; Buonato JM; Mathew LK; Bi Y; Davuluri RV; Martinez-Lage M; Simon MC; O'Rourke DM; Lazzara MJ
    Mol Cancer Res; 2015 Aug; 13(8):1227-37. PubMed ID: 25934697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma.
    Doll S; Urisman A; Oses-Prieto JA; Arnott D; Burlingame AL
    Mol Cell Proteomics; 2017 Jan; 16(1):39-56. PubMed ID: 27834733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotics possess anti-glioblastoma activity by disrupting lysosomal function and inhibiting oncogenic signaling by stabilizing PTEN.
    Jacob JR; Palanichamy K; Chakravarti A
    Cell Death Dis; 2024 Jun; 15(6):414. PubMed ID: 38871731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.